bf/NASDAQ:SANA_icon.jpeg

COM:SANA

Sana Biotechnology, Inc.

  • Stock

USD

Last Close

2.35

22/11 21:00

Market Cap

1.15B

Beta: -

Volume Today

1.82M

Avg: -

Company Overview

Metric
Company NameSana Biotechnology, Inc.Eterna Therapeutics Inc.GC TherapeuticsJaguar Gene Therapy
SymbolSANAERNA
MSH IDCOM:SANACOM:ETERNATXCOM:GC-TXCOM:JAGUARGENETHERAPY
MarketSTOCKSSTOCKSPRIVATEPRIVATE
SectorHealthcareHealthcareHealthcare & Health ServicesHealthcare & Health Services
IndustryBiotechnologyBiotechnologyBiotechnologyBiotechnology
CountryUSUSUSUS
StageSeries AVenture Round
Employee Count3288
Websitesana.combrooklynitx.comgc-tx.comjaguargenetherapy.com
LinkedInsana-biotechnology
Founders

Market Metrics

Metric
Market Cap1.15B9.90M
Enterprise Value
Monthly Web Traffic22.72K270.57K1.68K1
Web Traffic Growth1.040.55-0.43-1.00
Valuation
Raised Capital165M65M

Financial Performance

Metric
Revenue68K
Revenue (LTM)
Revenue (NTM)
Gross Profit-1.29M
EBITDA-19.55M
Operating Income-20.67M
Net Income-21.67M
EPS-4.08
Diluted EPS-4.08
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin-5.88
Operating Profit Margin-135.73
EBITDA Margin-287.51
Net Profit Margin-147.65
Return on Equity15.58
Return on Assets-0.44
Return on Capital Employed-0.50

Valuation Multiples

Metric
P/E Ratio-0.42
P/B Ratio2.34
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio192.73
EV Multiple2.09

Operational Metrics

Metric
Days Sales Outstanding12.71K
Days Payables Outstanding4.45K
Days Inventory Outstanding
Operating Cycle2.28K
Cash Conversion Cycle1.79K
Asset Turnover0.00

Cash Flow Metrics

Metric
Operating Cash Flow-20.41M
Free Cash Flow-20.43M
Cash Flow to Debt-0.38
Operating Cash Flow/Sales-101.81
Free Cash Flow Yield-2.54

Balance Sheet Metrics

Metric
Cash & Equivalents7.58M
Accounts Receivable527K
Inventory
Goodwill2.04M
Debt to Capitalization2.84
Debt to Assets0.79
Current Ratio0.73
Quick Ratio1.22

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue28.90
R&D to Revenue130.82
SG&A to Revenue252.08